Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Restructuring Costs: 2011-2020

Historic Restructuring Costs for Tg Therapeutics (TGTX) over the last 10 years, with Dec 2020 value amounting to $41.5 million.

  • Tg Therapeutics' Restructuring Costs rose 452.33% to $16.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $41.5 million, marking a year-over-year increase of 336.85%. This contributed to the annual value of $41.5 million for FY2020, which is 336.90% up from last year.
  • According to the latest figures from FY2020, Tg Therapeutics' Restructuring Costs is $41.5 million, which was up 336.90% from $9.5 million recorded in FY2019.
  • Tg Therapeutics' 5-year Restructuring Costs high stood at $41.5 million for FY2020, and its period low was $5.1 million during FY2016.
  • In the last 3 years, Tg Therapeutics' Restructuring Costs had a median value of $9.5 million in 2019 and averaged $19.6 million.
  • Data for Tg Therapeutics' Restructuring Costs shows a peak YoY skyrocketed of 336.90% (in 2020) over the last 5 years.
  • Over the past 5 years, Tg Therapeutics' Restructuring Costs (Yearly) stood at $5.1 million in 2016, then climbed by 17.79% to $6.0 million in 2017, then spiked by 30.50% to $7.9 million in 2018, then climbed by 20.72% to $9.5 million in 2019, then spiked by 336.90% to $41.5 million in 2020.